Psilocybin Therapy for Methamphetamine Use Disorder and HIV
Psilocybin Therapy for Methamphetamine Use Disorder and HIV
Not yet recruiting · NCT07756736 · Registry updated 2026-08-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Psilocybin Therapy for Methamphetamine Use Disorder and HIV | AIDS, Blood-Borne Infections, Chemically-Induced Disorders, Genital Diseases, HIV infectious disease, Infections, RNA Virus Infections, Slow Virus Diseases, Urogenital Diseases, amphetamine abuse, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, psychiatric disorder, sexually transmitted disease, substance-related disorder, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Not yet recruiting | Phase 2 | 2026-08-11 | NCT07756736 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Institute on Drug Abuse (NIDA) | 549 |
| Nicky Mehtani, MD, MPH | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| UCSF at Zuckerberg San Francisco General Hospital | San Francisco | United States | 1 |